Insulin promotes and sustains pancreatic cancer development by inducing tumorigenic inflammation, regulating lipid and glucose metabolic reprogramming, overcoming apoptosis via crosstalk with IGF-1, stimulating cancer metastasis, and activating tumor microenvironment formation (inflammation, fibrosis, and angiogenesis) [40]. The gene discussed is IGF1; the disease is familial pancreatic carcinoma.